European Neuroscience--Seventh Biennial FENS Forum.
The European Neuroscience--Seventh Biennial FENS Forum, held in Amsterdam, included topics covering new therapeutic developments in the field of neuroscience. This conference report highlights selected presentations on sodium channel inhibitors, ionotropic glutamate receptor antagonists, serotonin receptor modulators, and novel therapies for depression, pain and stroke. Investigational drugs discussed include ST-1936 (Sigma-Tau Industrie Farmaceutiche Riunite SpA), LY-392098 (Eli Lilly & Co) and Lu-AA21004 (H Lundbeck A/S/Takeda Pharmaceutical Co Ltd).
Hannan
Anthony J
AJ
University of Melbourne, Howard Florey Institute, Florey Neuroscience Institutes, Parkville, VIC 3010, Australia. anthony.hannan@florey.edu.au
D000818:Animals; D002491:Central Nervous System Agents / Q000494:pharmacology*; D002493:Central Nervous System Diseases / Q000188:drug therapy* / Q000503:physiopathology; D015195:Drug Design; D015507:Drugs, Investigational / Q000494:pharmacology*; D006801:Humans
D002491:Central Nervous System Agents; D015507:Drugs, Investigational